The clinical introduction of a radioactive and fluorescent hybrid tracer allowed for preoperative lymphatic mapping and intraoperative real-time fluorescence tracing of the sentinel lymph node (SLN) by a single injection. The aim of this feasibility study is to evaluate the first-in-human use of the hybrid tracer by combining indocyanine green (ICG) and radiocolloid based on Nanotop compound (Tc Nanotop) for SLN biopsy (SLNB) in breast cancer patients.
Novel Experience in Hybrid Tracers: Clinical Evaluation of Feasibility and Efficacy in Using ICG-99mTC Nanotop for Sentinel Node Procedure in Breast Cancer Patients
Manca, Gianpiero;Garau, Ludovico Maria;Mazzarri, Sara;Mazzuca, Laura;Muccioli, Simona;Naccarato, Giuseppe;Roncella, Manuela;Volterrani, Duccio;
2020-01-01
Abstract
The clinical introduction of a radioactive and fluorescent hybrid tracer allowed for preoperative lymphatic mapping and intraoperative real-time fluorescence tracing of the sentinel lymph node (SLN) by a single injection. The aim of this feasibility study is to evaluate the first-in-human use of the hybrid tracer by combining indocyanine green (ICG) and radiocolloid based on Nanotop compound (Tc Nanotop) for SLN biopsy (SLNB) in breast cancer patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
